Siemens Healthineers has a released an informative eBook titled “Coagulation abnormalities in COVID-19 patients – current testing and treatment protocols” to provide quick access to coagulation testing and treatment recommendations.
The eBook can be downloaded for free from their website: https://bit.ly/2CcpB5I Because coagulation tests are important in the management of COVID-19 patients, the company has compiled an eBook for quick access to:
- Thrombosis risk factors
- An ISTH-recommended coagulation testing algorithm
- Leading recommendations for anticoagulation treatment
- Relevant parameters for patient monitoring
The eBook provides an overview of COVID-19 and thrombosis; it looks at laboratory testing in the identification of coagulation abnormalities in COVID-19 patients; and provides information on the treatment of coagulation abnormalities in COVID-19 patients.
Authors of the eBook write that while it’s not unusual for infections to raise the risk of clotting, the COVID-19 virus is associated with an unprecedented range of clotting-related disorders in affected patients. “From benign skin lesions on the feet to life-threatening thrombotic events, the COVID-19 virus has demonstrated a strikingly high prevalence of deadly blood clots. Studies show that about 25% and even up to 70% of critically ill patients have confirmed venous thromboembolism or pulmonary embolism. Another study found that approximately 70% of COVID-19 patients who died had disseminated intravascular coagulation.”
They add that Siemens Healthineers’s coagulation tests play an important role in the diagnosis, treatment, and management of coagulation abnormalities in COVID-19 patients and point out that the company has changed their production model to produce these assays at a higher volume than ever before.
“We are proud to support you in the fight against COVID-19. Behind every healthcare professional there are 53,000 Healthineers,” Siemens Healthineers says.
Supplier: Siemens Healthineers